- MCA filings & documents
- P&L, balance sheet, cash flow & ratios
- Year-wise charts & analysis
- One credit = one full company report
- Use across any company, anytime
- Credits valid for 12 months
Key Metrics
Company Health Scores
Health scores for Albany Molecular Research covering vendor trust, statutory compliance, financial health and director risk - derived from MCA filings, GST and EPFO records, financial statements and the company's board history.
- Blend of compliance (86), financial health (80), director (55) and company-foundation signals.
- Operating for 21+ years.
- Company status is Active as per MCA.
- Annual filings up to date (balance sheet as of Mar 2025).
- Profitable in FY 2023.
- Positive net worth.
- 6 directors on the board.
- Director JAMES FRANCIS GRABOWSKI JR has DIN status "Deactivated due to non-filing of DIR-3 KYC".
About Albany Molecular Research
Albany Molecular Research is an MCA-registered Indian company: a Private Limited Indian Non-Government Company (CIN U73200TG2005PTC045178). Business overview includes Pharma (Pharma Contract R&D), incorporated on January 25, 2005 (21+ years old), headquartered in Hyderabad, Telangana, India. The company is currently Active with Active Compliant compliance status.
- Location No: 9, Sy No: 230-243, Phase-I, Mn Park,Turkapally Shamirpet Mandal, Genome Valley, Hyderabad, Telangana - 500078
- Website curiaglobal.com
Financial Performance of Albany Molecular Research
| Metrics | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Profit/Loss | — | — | — | — | — |
| Cash & Bank Balance | — | — | — | — | — |
| Net Worth | — | — | — | — | — |
| EBITDA | — | — | — | — | — |
Financial Ratios
Sign in to view ratio trends
| Ratio | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|
| Net Profit Margin | — | — | — | — | — |
| Debt to EBITDA | — | — | — | — | — |
| Interest Coverage Ratio | — | — | — | — | — |
| Debt to Equity | — | — | — | — | — |
| Return on Equity | — | — | — | — | — |
| Current Ratio | — | — | — | — | — |
| Quick Ratio | — | — | — | — | — |
| EBITDA Margin | — | — | — | — | — |
| Return on Capital Employed | — | — | — | — | — |
| Earning Per Share | — | — | — | — | — |
EPFO Establishments (1)
Current Directors of Albany Molecular Research (6)
Charges of Albany Molecular Research
| Lender | Amount | Status |
|---|---|---|
|
The Cosmos Co-Operative Bank Limited
Creation Date: 05 Jul 2004 |
10.00 Lakh | Open |
|
The Cosmos Co-Operative Bank Limited
Creation Date: 08 Jun 2004 |
15.00 Lakh | Open |
|
The Cosmos Co-Operative Bank Limited
Creation Date: 12 Apr 2004 |
25.00 Lakh | Open |
Business Activity
| Activity Group | Description | Turnover % |
|---|---|---|
| Manufacturing | - | 59.74 |
| Professional, Scientific and Technical | - | 40.26 |
Flagged By Authority
Regulatory and exchange flags (preview)
Disclaimer: Data on this page is compiled from public sources as available in our system at the time of the last update and is for general information only. Scores are derived indicators, not credit ratings or advice - please verify from official sources and consult a professional before making any business or financial decision.
